Comments
Loading...
Cassava Sciences (SAVA) Forecast
NewsEarningsCassava Sciences (SAVA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestCassava Sciences (NASDAQ:SAVA) Stock Quotes, Forecast and News Summary
Cassava Sciences Stock (NASDAQ: SAVA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cassava Sciences (SAVA) stock?
You can purchase shares of Cassava Sciences (NASDAQ:SAVA) through any online brokerage.
Who are Cassava Sciences (SAVA) competitors?
Other companies in Cassava Sciences’s space includes: WAVE Life Sciences (NASDAQ:WVE), Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS), Phibro Animal Health (NASDAQ:PAHC) and Rapport Therapeutics (NASDAQ:RAPP).
What is the forecast, or price target, for Cassava Sciences (SAVA) stock?
Cassava Sciences has a consensus price target of $89.00.
What is the current price for Cassava Sciences (SAVA)?
The stock price for Cassava Sciences (NASDAQ: SAVA) is $4.595 last updated November 25, 2024 at 2:14 PM EST.
Does Cassava Sciences (SAVA) pay a dividend?
A quarterly cash dividend of 0.75 per share of Class A Common Stock. The quarterly cash dividend was payable on December 24, 2012 to stockholders of record on December 13, 2012.
When is Cassava Sciences (NASDAQ:SAVA) reporting earnings?
Cassava Sciences’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Cassava Sciences (SAVA) going to split?
There is no upcoming split for Cassava Sciences.
What sector and industry does Cassava Sciences (SAVA) operate in?
Cassava Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.